Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Oct 29

PMID 33114496

Citations 7

Authors

Sadia Rahman

Karlo Wittine

Mirela Sedic

Elitza P Markova-Car

Affiliations

Soon will be listed here.

Abstract

The circadian rhythms are an intrinsic timekeeping system that regulates numerous physiological, biochemical, and behavioral processes at intervals of approximately 24 h. By regulating such processes, the circadian rhythm allows organisms to anticipate and adapt to continuously changing environmental conditions. A growing body of evidence shows that disruptions to the circadian rhythm can lead to various disorders, including cancer. Recently, crucial knowledge has arisen regarding the essential features that underlie the overt circadian rhythm and its influence on physiological outputs. This knowledge suggests that specific small molecules can be utilized to control the circadian rhythm. It has been discovered that these small molecules can regulate circadian-clock-related disorders such as metabolic, cardiovascular, inflammatory, as well as cancer. This review examines the potential use of small molecules for developing new drugs, with emphasis placed on recent progress that has been made regarding the identification of small-molecule clock modulators and their potential use in treating cancer.

Citing Articles

Design, synthesis and evaluations of new cyclotriphosphazenes as safe drug candidates.

Yildiz Gul E, Tiryaki B, Kose B, Ozturk N, Okutan E, Dedeoglu B RSC Med Chem. 2025; .

PMID: 40027348 PMC: 11865950. DOI: 10.1039/d4md00885e.

Circadian rhythm of cutaneous pruritus.

Jiang Z, Sang X, Lu J, Gao L Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(2):190-196.

PMID: 38755715 PMC: 11103053. DOI: 10.11817/j.issn.1672-7347.2024.230397.

Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.

Santoni M, Molina-Cerrillo J, Santoni G, Lam E, Massari F, Mollica V Cancers (Basel). 2023; 15(2).

PMID: 36672355 PMC: 9856936. DOI: 10.3390/cancers15020408.

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials.

Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y J Hematol Oncol. 2022; 15(1):21.

PMID: 35246220 PMC: 8896306. DOI: 10.1186/s13045-022-01238-y.

Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance.

Bevinakoppamath S, Ramachandra S, Yadav A, Basavaraj V, Vishwanath P, Prashant A Front Pharmacol. 2022; 12:719631.

PMID: 35126099 PMC: 8807567. DOI: 10.3389/fphar.2021.719631.

References

Zeng Z, Luo H, Yang J, Wu W, Chen D, Huang P . Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2013; 20(4):1042-52. DOI: 10.1158/1078-0432.CCR-13-0171. View

Fu L, Pelicano H, Liu J, Huang P, Lee C . The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002; 111(1):41-50. DOI: 10.1016/s0092-8674(02)00961-3. View

Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R . Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014; 13(20):3282-91. PMC: 4613905. DOI: 10.4161/15384101.2014.954454. View

Eide E, Woolf M, Kang H, Woolf P, Hurst W, Camacho F . Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol. 2005; 25(7):2795-807. PMC: 1061645. DOI: 10.1128/MCB.25.7.2795-2807.2005. View

Takahashi J, Hong H, Ko C, McDearmon E . The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008; 9(10):764-75. PMC: 3758473. DOI: 10.1038/nrg2430. View

Fabian M, Biggs 3rd W, Treiber D, Atteridge C, Azimioara M, Benedetti M . A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol. 2005; 23(3):329-36. DOI: 10.1038/nbt1068. View

Ou J, Li H, Qiu P, Li Q, Chang H, Tang Y . CDK9 modulates circadian clock by attenuating REV-ERBα activity. Biochem Biophys Res Commun. 2019; 513(4):967-973. DOI: 10.1016/j.bbrc.2019.04.043. View

Siddiqui-Jain A, Drygin D, Streiner N, Chua P, Pierre F, OBrien S . CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 2010; 70(24):10288-98. DOI: 10.1158/0008-5472.CAN-10-1893. View

Tamaru T, Hirayama J, Isojima Y, Nagai K, Norioka S, Takamatsu K . CK2alpha phosphorylates BMAL1 to regulate the mammalian clock. Nat Struct Mol Biol. 2009; 16(4):446-8. PMC: 6501789. DOI: 10.1038/nsmb.1578. View

10.

Kolarski D, Sugiyama A, Breton G, Rakers C, Ono D, Schulte A . Controlling the Circadian Clock with High Temporal Resolution through Photodosing. J Am Chem Soc. 2019; 141(40):15784-15791. PMC: 6787957. DOI: 10.1021/jacs.9b05445. View

11.

Visconti R, Della Monica R, Palazzo L, DAlessio F, Raia M, Improta S . The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs. Cell Death Differ. 2015; 22(9):1551-60. PMC: 4532778. DOI: 10.1038/cdd.2015.13. View

12.

Cheong H, Lu C, Lindsten T, Thompson C . Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol. 2012; 30(7):671-8. PMC: 3876738. DOI: 10.1038/nbt.2285. View

13.

Hansen J . Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001; 12(1):74-7. DOI: 10.1097/00001648-200101000-00013. View

14.

Malumbres M, Barbacid M . Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009; 9(3):153-66. DOI: 10.1038/nrc2602. View

15.

Yu E, Weaver D . Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY). 2011; 3(5):479-93. PMC: 3156599. DOI: 10.18632/aging.100323. View

16.

De Mei C, Ercolani L, Parodi C, Veronesi M, Lo Vecchio C, Bottegoni G . Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. Oncogene. 2014; 34(20):2597-608. PMC: 4761647. DOI: 10.1038/onc.2014.203. View

17.

Galluzzi L, Pietrocola F, Bravo-San Pedro J, Amaravadi R, Baehrecke E, Cecconi F . Autophagy in malignant transformation and cancer progression. EMBO J. 2015; 34(7):856-80. PMC: 4388596. DOI: 10.15252/embj.201490784. View

18.

Chen S, Choo K, Hou M, Yeh K, Kuo S, Chang J . Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005; 26(7):1241-6. DOI: 10.1093/carcin/bgi075. View

19.

Hastings M, Maywood E, Brancaccio M . Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018; 19(8):453-469. DOI: 10.1038/s41583-018-0026-z. View

20.

Tang Q, Cheng B, Xie M, Chen Y, Zhao J, Zhou X . Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma. Cancer Res. 2016; 77(2):532-544. DOI: 10.1158/0008-5472.CAN-16-1322. View